about
Dopamine Transporter Density in the Basal Ganglia in Obsessive-Compulsive Disorder, Measured with [123I]IPT SPECT before and after Treatment with Serotonin Reuptake InhibitorsRisk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapyComparison of standardized uptake value of 18F-FDG-PET-CT with 21-gene recurrence score in estrogen receptor-positive, HER2-negative breast cancer.Optimization of the radiosynthesis of [(18) F]MEFWAY for imaging brain serotonin 1A receptors by using the GE TracerLab FXFN-Pro module.Acute physical stress induces the alteration of the serotonin 1A receptor density in the hippocampus.Translational possibility of [(18) F]Mefway to image serotonin 1A receptors in humans: Comparison with [(18) F]FCWAY in rodents.Dopaminergic neuron destruction reduces hippocampal serotonin 1A receptor uptake of trans-[(18)F]Mefway.[18F]-fluorodeoxyglucose positron emission tomography can contribute to discriminate patients with poor prognosis in hormone receptor-positive breast cancerRebound thymic hyperplasia detected by 18F-FDG PET/CT after radioactive iodine ablation therapy for thyroid cancer.A computed tomography-based spatial normalization for the analysis of [18F] fluorodeoxyglucose positron emission tomography of the brain.Standardized uptake value of ¹⁸F-fluorodeoxyglucose positron emission tomography for prediction of tumor recurrence in breast cancer beyond tumor burden.18F-Mefway PET imaging of serotonin 1A receptors in humans: a comparison with 18F-FCWAYFeasibility of Computed Tomography-Guided Methods for Spatial Normalization of Dopamine Transporter Positron Emission Tomography Image.Relationship Between 18F-Fluorodeoxyglucose Uptake and V-Ki-Ras2 Kirsten Rat Sarcoma Viral Oncogene Homolog Mutation in Colorectal Cancer Patients: Variability Depending on C-Reactive Protein Level.Saline flush effect for enhancement of aorta and coronary arteries at multidetector CT coronary angiography.Optimal timing of [¹⁸F]Mefway PET for imaging the serotonin 1A receptor in healthy male subjects.[(18)F]FPEB and [(18)F]FDEGPECO comparative study of mGlu5 quantification in rodent brain.Analysis of the roles of glucose transporter 1 and hexokinase 2 in the metabolism of glucose by extrahepatic bile duct cancer cells.The role of ultrasonography and FDG-PET in axillary lymph node staging of breast cancer.Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.F-18 FDG PET scan findings in patients with Loeffler's syndrome.Initially non-diagnostic ultrasound-guided fine needle aspiration cytology of thyroid nodules: value and management.The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.Head to head comparison of [(18)F] AV-1451 and [(18)F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia.Effects of disease duration on the clinical features and brain glucose metabolism in patients with mixed type multiple system atrophy.Radiation dosimetry and biodistribution in monkey and man of 11C-PBR28: a PET radioligand to image inflammation.Differential CT features of infectious pneumonia versus bronchioloalveolar carcinoma (BAC) mimicking pneumonia.Accuracy of fluorodeoxyglucose-positron emission tomography for diagnosis of single bone metastasis: comparison with bone scintigraphy.Environmental enrichment enhances synaptic plasticity by internalization of striatal dopamine transporters.Effects of hypothyroidism on serotonin 1A receptors in the rat brain.18F-AV-1451 binds to motor-related subcortical gray and white matter in corticobasal syndrome.Low iodine diet for one week is sufficient for adequate preparation of high dose radioactive iodine ablation therapy of differentiated thyroid cancer patients in iodine-rich areas.Relationship between dopamine deficit and the expression of depressive behavior resulted from alteration of serotonin system.[(18)F] FP-CIT PET study in parkinsonian patients with leukoaraiosis.Evaluation of dopamine transporters and D2 receptors in hemiparkinsonian rat brains in vivo using consecutive PET scans of [18F]FPCIT and [18F]fallypride.Subcortical 18 F-AV-1451 binding patterns in progressive supranuclear palsy.Biodistribution and Radiation Dosimetry of [18F]Mefway in Humans.Distinct patterns of amyloid-dependent tau accumulation in Lewy body diseases.Striatal dopamine loss and discriminative sensory dysfunction in Parkinson's disease.Tau PET in Alzheimer disease and mild cognitive impairment.
P50
Q22299319-94B4ED29-8C4D-4DAB-B00E-C6A67ABAD468Q28542679-F4C3ACDC-6229-4D1F-B958-66913439F557Q33574310-E5021AC2-FB5D-449A-8D3E-A03D369E50CDQ34039144-EE28C112-8620-450A-9888-DD8DEC6615B8Q34040758-AA3BB66D-9641-4E5E-A289-6FC837833357Q34041532-7941463E-571B-4F05-A36F-D8829E0322A9Q34041567-FC41B640-C2FA-44EF-B96E-1CEC9947151DQ34105060-3A048A5B-996A-459F-9D0D-364F0BE90864Q34499913-07CBF05F-089E-425F-9B87-085A782E3E05Q34592334-8C56C0B2-4181-47BD-9E5C-374768AD1F87Q35021092-FEE2CAE1-11B6-41CF-A29F-741CB9061503Q35241015-E990B58A-7D9D-4BC3-AC79-8E017BF1AE76Q35683827-387CD3A8-6B09-4705-AC56-E729A9997556Q36445004-75AA5DFA-420E-441B-B2B0-9FA0714EF828Q37039259-E41B3DD0-F0B9-4A31-BEC3-A999B1E92B9CQ40402919-C5EAD977-0F80-4DAD-824F-A4BB1E3E83A5Q41470179-920C8195-CD69-4635-B232-E1261E76DE0BQ41548902-2B7DE7E5-B58D-491B-A46A-87C28243BA3CQ42952521-33B3EED1-763B-4B8A-B9C2-9D90C1A4F070Q42981268-573AECA9-F059-4862-B495-65099913115FQ43289405-59B26675-6D82-4FC0-AA92-EC80AC822889Q44412555-CB532524-84C7-430B-9280-4EB59856449CQ45168631-8228B847-C4AD-447F-9FFF-DCF4739E4E98Q46753514-C1D7F172-241C-418B-B7C9-E71BE1CC4536Q46820386-13363198-29D4-4E42-822A-CF1BB07B7CDAQ46897712-DB09E6FA-3209-4ACD-B7B7-9EE5AEDD3593Q46898322-9580E39C-F071-465B-A5CB-C5F86F7CF32EQ46981793-A8B32D55-A9E6-4761-9012-668431A2BF56Q47220512-7CA10BD8-DA23-4C8F-8AA8-F0B640A50FF9Q47361475-FB5D0DB4-DEF6-43B3-8BAE-D2F6791A3DEAQ47944653-E2ECB0FD-A11C-4B15-B491-FD317F9C0DB1Q48079870-76F6E1D6-BE91-4A8B-A557-6466FB29A866Q48080132-A3C97811-F9C5-4639-8139-43A32BD43747Q48195190-934A685B-9B76-4BB9-95C9-537247F28A80Q48346909-77359313-11C6-45B2-ADD4-F2CC364CCB49Q48440202-59BF2003-DFE3-4268-A311-6DA2BF57BD79Q48445004-91AE9A57-D2D5-4EA3-B1B1-EE26F7EFEA06Q48550610-2E1721B5-5517-4E1F-AAF2-39F264B90404Q48634067-671C7075-56B0-4B72-90ED-FEACD1B35790Q48648902-083FC507-BA38-4999-9A26-F0CE90ABD469
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Young Hoon Ryu
@ast
Young Hoon Ryu
@en
Young Hoon Ryu
@es
Young Hoon Ryu
@nl
type
label
Young Hoon Ryu
@ast
Young Hoon Ryu
@en
Young Hoon Ryu
@es
Young Hoon Ryu
@nl
prefLabel
Young Hoon Ryu
@ast
Young Hoon Ryu
@en
Young Hoon Ryu
@es
Young Hoon Ryu
@nl
P106
P31
P496
0000-0002-9000-5563